Alpine Global Management’s Apogee Therapeutics APGE Stock Holding History
Bought
Maintained
Sold
Other funds holding APGE
Alpine Global Management's APGE Position: Q3 2026 in Review
Alpine Global Management sold out of Apogee Therapeutics (APGE) in Q3 2026, closing a stake of 32,500 shares — an estimated $4.31M sold.
Alpine Global Management first reported a position in APGE in Q2 2026 and held it in 1 quarter. The position peaked at $4.31M in Q2 2026. 2 funds tracked by Wall St. Rank hold APGE as of Q3 2026.
- Alpine Global Management reported no remaining Apogee Therapeutics position as of Q3 2026 after selling out during the quarter.
- Alpine Global Management sold 32,500 Apogee Therapeutics shares in Q3 2026, an estimated $4.31M.
- Alpine Global Management first reported a position in Apogee Therapeutics in Q2 2026 and held it in 1 quarter.
- Alpine Global Management's Apogee Therapeutics position peaked at $4.31M in Q2 2026.
- 2 funds tracked by Wall St. Rank held Apogee Therapeutics as of Q3 2026.
Based on Alpine Global Management's 13F filing for Q3 2026, filed 16 Nov 2026.